medigraphic.com
ISSN 0210-5187 (Electronic)

2003, Number 5

<< Back Next >>

Med Cutan Iber Lat Am 2003; 31 (5)

Eccrine Syringofibroadenoma: Report of an Unusual Case and Review of 60 Cases of Literature

Souza LC, Wei YS, Swery MN, Peres RI, Santos ML, Porro AM

Language: Portugués
References: 44
Page: 304-309
PDF size: 242.92 Kb.


ABSTRACT

Eccrine syringofibroadenoma (ESFA) is a rare cutaneous adnexal disorder wich shows proliferating ductular structures resembling the acral portion of the eccrine duct. There is some controversy concerning the pathogenesis and precise differentiation of this new entity: tumor, hamartoma or reactive hyperplasia. We report a case of a 23-years-old woman who had a slowly growing lesion on her back after surgery on the same area. The histopathological findings ressembled ESFA. We suggest that this lesion has been induced by the inflammation following surgery.


REFERENCES

  1. Mascaro JM. Considérations sur les tumeurs fibro-épithéliales. Annales de Dermayologie el de Syphiligrafie 1963;2:146-53.

  2. Pinkus H. Premalignant fibroepithelial tumors of skin. AM.A Archives of Dermathology and Syphilology 1954;67:598-615.

  3. Kanitakis J, Zambruno G, Euvrard S, Hermier C, Thivolet J. Eccrine syringofibroadenoma:immunohistological study of a new case. Am J Dermatopathol 1987;9:37-40.

  4. Hurt MA, Igra-Serfaty H, Stevens CS. Eccrine syringofibroadenoma (Mascaró). Arch Dermatol 1990;126:945-49.

  5. Nomura K, Kogawa T, Hashimoto I, Katabira Y. Eccrine syringofibroadenomatous hyperplasia in a patient with bullous pemphigoid: a case report and review of the literature. Dermatologica 1991;182:59-62.

  6. Nomura K, Hashimoto I. Eccrine syringofibroadenomatosis in two patients with bullous pemphigoid. Dermatology 1997;195:395-98.

  7. Hara K, Mizuno e, Nitta Y, et al. Acrosyringeal adenomatosis (eccrine syringofiboadenoma of Mascaró): a case report and review of the literature. Am J Dermatopathol 1992;14:328-39.

  8. French LE, Masgrau E, Chavaz P, Saurat J-H. Eccrine syringofibroadenoma in a patient with erosive palmoplantar lichen planus. Dermatology 1997;195:399-01.

  9. Starink TM. Eccrine syringofibroadenoma: multiples lesions representing a new cutaneous marker of the Schöpf syndrome, and solitary nonhereditary tumors. J Am Acad Dermatol 1997;36:569-76.

  10. Chen S, Palay D, Templeton SF. Familial eccrine syringofibroadenoamtosis with associated ophthalmologic abnormalities. J Am Acad Dermatol 1998;39:356-8.

  11. Goldner R. Eccrine poromatosis. Arch Dermatol 1970;101:606-8.

  12. Ogino A. Linear eccrine poroma. Arch dermatol 1976;112:841-4.

  13. Wilkinson RD, Schopflocher p, Rozenfeld M. Hidrotic ectodermal dysplasia with diffuse eccrine poromatosis. Arch Dermatol 1977;113:472-6.

  14. Weedon D, Lewis J. Acrosyringeal nevus. J Cutan Pathol 1977;4:166-8.

  15. Olmos L. Syringofibroadenoma ecrino de Mascaró. Acta Dermo Sifilogr 1980;71:73-6.

  16. Civatte J, Jeanmougin M, Barrandon Y, et al. Syringofibroadenoma ecrino de Mascaró: discusion de un caso. Med Cután Ibero-Lat Am 1981;9:193-6.

  17. Mehregan AH, Marufi M, Medenica M. Eccrine syringofibroadenoma (Mascaro): report of two cases. J Am Acad Dermatol 1985; 13:433-6.

  18. Sanusi ID, Byrd LN. Eccrine syringofibroadenoma. Int J Deramtol 1988;27:523-5.

  19. Nordin H, Mansson T, Svensson A. Familial occurrence of eccrine tumors in a family with ectodermal dysplasia. Acta Derm Venereol (Stockh) 1988;68:523-30.

  20. Hulsmans RFHJ, Van de Staak WJBM. Hidrocystoma-Hypotrichose-Hypodontie-Hyperkeratose syndroom. 244ste Wetenschappelijke Vergadering Nederlandse Vereniging voor Dermatologie en Venereologie. Glaxo, Nieuwegein 1988;8-9.

  21. Aloi FG, Torre C. Hidrotic ectodermal dysplasia with diffuse eccrine syringofibroadenomatosis [letter]. Arch Dermatol 1989;125:1715.

  22. Anda G, Vignale R, Mowszowicz M, Aguerre S. Siringofibroadenoma écrino de Mascaro. Ver. Argentina de Dermatología 1989;70:7-11.

  23. Hamm H, Orge C, Bröcker E-B. Das Schöpf-syndromeine “Blickdiagnose” unter den ektodermale Dysplasien [abstract]. Zentralbl Haut Geschl Krankh 1990;57:940.

  24. Billson VR, Dyall-Smith Dj. Eccrine syringofibroadenoma: a report of 2 cases. Pathology 1991;23:259-62.

  25. De Viragh PA, Meylan R, Montaldi G, et al. Das ekkrine Syrigofibroadenom. Bericht über Klinik und Histologie zweier Fälle met Literaturübersicht. Hautarzt 1992;43:724-7.

  26. EckertF, Nilles M, Altmannsberger M. Eccrine syringofibroadenoma: a case report with analysis of cytokeratin expression. Br J Deramtol 1992;126:257-61.

  27. Lui H, Stewart WD, English JC, et al. Eccrine syringofibroadenomatosis: a clinical and histologic study and review of the literature. J Am Acad Dermatol 1992;26:805-13.

  28. Sueki H, Miller SJ, Dzubow LM, et al. Eccrine syringofibroadenoma (Mascaro): an ultrastructural and immunohistochemical study. J Cutan Pathol 1992;19:232-9.

  29. Ochonisky S, Wechsler J, Marinho E. et al. Eccrine syringofibroadenomatosis (Mascaró) with mucous involvement. Arch Dermatol 1994;130:993-4.

  30. Sobânia LRS, Barreto AW, Kanasiro T, Bovo D,Fillus JN, Siringofibroadenoma écrino: relato de caso. An Bras Dermatol 1994;69:491-493.

  31. Betti R, Inselvini E, Moneghini L, et al. Solitary eccrine syringofibroadenoma. Eur J Dermatol 1995;5:142-4.

  32. Ohnishi T, Suzuki T, Watanabe S. Eccrine syringofibroadenoma. Report of a case and immunohistochemical study of keratin expression. Br J Dermatol 1995;134:449-54.

  33. Gambini C, Rongioletti F, Parodi A, et al. Solitary and multiple eccrine syringofibroadenomas: report of a two cases [abstract]. J Eur Acad Dermatol Vener 1995;5(suppl):192.

  34. Fretzin DF, Sloan JB, Beer K, Fretzin SA. Eccrine syringofibroadenoma: a clear cell variant. Am J Dermatophatol 1995;17;591-3.

  35. Ishida-Yamamoto A, Iizuka H. Eccrine syringofibroadenoma (Mascaro): na ultrastructural and immunohistochemical study. Am J Dermatophatol 1996;18:207-11.

  36. González-Serva A, Pró-Rísquez M A, Oliver M, Caruso MG. Syringofibroadenoma versus squamous cell carcinoma involving syringofibroadenoma: is there a malignant counterpart of Mascaró syringofibroadenoma?. Am J Dermatopathol 1997;19:58-5.

  37. Simpson EL, Styles AR, Cockerell CJ. Eccrine syringofibroadenomatosis associated with hidrotic ectodermal dysplasia. Br J Dermatol 1998;138:879-84.

  38. Takeda H, Mitsuhashi Y, Yoshikawa K, Katagat Y, Kondo S. Eccrine syringofibroadenoma: report of a case and analysis of cytokeratin expression. Dermatology 1998;196:242-45.

  39. Utani A, Yabunami H, Kakuta T, Endo H, Shinkai H. Reactive eccrine syringofibroadnoma: na association with chronic foot ulcer in a patient with dibetes mellitus. J Am Acad Dermatol 1999;650-1.

  40. Trauner MA, Narurkar VA, Ruben BS. Eccrine syringofibroadenoma treated with dual pulse with flashlamp pumped pulsed dye laser. Dermatol Surg 1999; 25:418-20.

  41. Carlson JA, Rohwedder A, Daulat S, Schwartz J, Schaller J. Detection of human papillomavirus type 10 DNA in eccrine syringofibroadenomatosis occuring in Clouston,s syndrome. J Am Acad Dermatol 1999;40:259-62.

  42. Van Leeuwen RL, Lavrijsen APM, Starink TM. Eccrine syringofibroadenoma: the simultaneous occurrence of two histopathological variants (conventional and clear-cell type) in one patient. Br J Dermatol 1999[correspondence];141:947-49.

  43. Komine M, Hattori N, Tamaki K. Eccrine syringofibroadenoma (Mascaro): na immunohistochemical study. Am J Dermatopathol 2000;22:171-75.

  44. Noguchi M, Akiyama M, Kawakami M, Nagashima T, Niizuma K, Matsuo I. Eccrine syringofibroadenoma developing in a sebaceous naevus. Br J Dermatol 2000[correspondence];142:1050-51.




2020     |     www.medigraphic.com